Cancer is a complex and heterogeneous disease that challenges healthcare professionals with its unpredictable behavior and resistance to treatment. Currently, personalized cancer treatment is getting more attention for its efficiency as a remedy for patients. Artificial intelligence (AI) has the potential to revolutionize personalized medicine by enabling more accurate and efficient diagnoses, treatment selection, and disease prediction, for instance, cancer, diabetes, and many genetic defects. AI algorithms can analyze large amounts of patient data, including genomic data, medical history, and lifestyle factors, to identify patterns and predict disease risk, treatment effectiveness, and potential adverse reactions. AI can also support the development of personalized treatment plans based on the unique characteristics of each patient, such as their genetic makeup, disease stage, and health history. This approach, known as precision medicine, can significantly improve patient outcomes and reduce healthcare costs by focusing on the most effective treatments for each individual. Moreover, AI-powered tools can help clinicians identify patients at high risk of developing a particular disease and intervene early to prevent or delay its onset. This can be particularly crucial for chronic diseases like diabetes and heart disease, which can be managed more effectively with early intervention.

Furthermore, AI can significantly improve research efficiency and outcomes in personalized medicine by enhancing patient stratification during clinical trials. By leveraging AI-driven algorithms, researchers can identify and group patients based on various factors, such as genetic profiles, disease characteristics, and treatment responsiveness. It should be noted that the impact of AI on personalized medicine is still being explored, and there are many opportunities for this technology to transform healthcare in the coming years. However, it is crucial to ensure that AI is used ethically and responsibly to respect patient privacy and guarantee the accuracy and reliability of the data being analyzed. This review article explores how artificial intelligence can improve prognosis and personalized cancer immunotherapies.